Caricamento...
P01.111 Using the ASCO and ESMO frameworks to assess the clinical value of tumor treating fields for newly diagnosed Glioblastoma multiforme
BACKGROUND: The effectiveness and safety of TTFields in newly diagnosed GBM was recently demonstrated by the final analysis of the large, randomised controlled EF-14 Trial. To account for the need of physicians and policymakers to objectively and comparably capture the clinical value of new cancer t...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144005/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.153 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|